Top

Published in:

Open Access 01-04-2010 | Meeting abstract

Is amisulpride associated less with neuroleptic malignant syndrome? Review and hypothesis

Authors: Vaios Peritogiannis, Georgios Kalampokis, Charalampos Lixouriotis

Published in: Annals of General Psychiatry | Special Issue 1/2010

Excerpt

Atypical antipsychotics have been reported to induce neuroleptic malignant syndrome (NMS). The precise pathophysiologic mechanism is unknown but dopamine blockage is pivotal. The serotoninergic action of atypical antipsychotics may also been implicated because serotonin may inhibit dopamine release and worsen hypodopaminergic states. Amisulpride, which is a selective D2/D3 receptor antagonist and has no affinity for serotonin receptors may be less associated with the development of NMS. …

Title: Is amisulpride associated less with neuroleptic malignant syndrome? Review and hypothesis
Authors: Vaios Peritogiannis
Georgios Kalampokis
Charalampos Lixouriotis
Publication date: 01-04-2010
Publisher: BioMed Central
Published in: Annals of General Psychiatry / Issue Special Issue 1/2010
Electronic ISSN: 1744-859X
DOI: https://doi.org/10.1186/1744-859X-9-S1-S158

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Is amisulpride associated less with neuroleptic malignant syndrome? Review and hypothesis

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2010

EPA and Huntington's chorea: treatment and associated cerebral changes

A preliminary study of functional imaging upon placebo analgesia in progressive multiple sclerosis

Treatment guidelines for acute bipolar depression

Cross-cultural psychopharmacology: a review

Why treating early, treating well, and treating for life is important in schizophrenia

Psychological status and breath at children with psychosomatic pathology